ArticleBMC psychiatry2026
Discrimination of generalized anxiety and major depressive disorders by machine learning of resting-state functional MRI.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo address the clinical difficulty of differentiating Generalized Anxiety Disorder (GAD) from Major Depressive Disorder (MDD), this study aimed to create a machine learning framework with strong interpretability, leveraging a comprehensive suite of resting-state functional MRI features to enhance potential relevance.
methodsA comprehensive set of functional measures, encompassing both local neural activity and global functional connectivity, was extracted as neuroimaging features from resting-state fMRI data. These data were obtained from 91 patients with Generalized Anxiety Disorder (GAD), 94 with Major Depressive Disorder (MDD), and 71 healthy controls (HCs). Five machine learning algorithms were used for classification, with performance estimated within a rigorous nested cross-validation framework. Then, partial correlations were conducted to assess the associations between top-ranked contributive neuroimaging features and symptom severity.
resultsFor the discrimination tasks, the machine learning models achieved area under the curve (AUC) values of 0.783 (GAD vs. MDD), 0.824 (GAD vs. HCs), and 0.867 (MDD vs. HCs), demonstrating moderate classification performance. Feature importance analysis revealed that precuneus function served as a prominently differential neurobiological signature and it showed opposing relationships with the severity of anxiety (positive correlation) and depression (negative correlation) across different diagnostic categories.
conclusionThese findings could guide the creation of a computational framework based on neuroimaging to effectively differentiate GAD from MDD. This is underscored by the pivotal role that the precuneus appears to play in the neurobiological processes associated with symptoms of both disorders.
trial registrationThis is a non-interventional study with a control group. Clinical trial registration is not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.